About Amneal
Amneal is a company based in Bridgewater (United States) founded in 2002.. The company has 8,300 employees as of December 31, 2024. Amneal has completed 6 acquisitions, including AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories. Amneal offers products and services including Generic Products, Specialty Products, and Biosciences Products.
- Headquarter Bridgewater, United States
- Employees 8300 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amneal Pharmaceuticals, Inc.
-
Annual Revenue
$2.79 B16.73as on Dec 31, 2024
-
Net Profit
$-116.89 M-39.16as on Dec 31, 2024
-
EBITDA
$589.48 M19.71as on Dec 31, 2024
-
Latest Funding Round
$19.2 M (USD), Post-IPO
Nov 16, 2018
-
Investors
Northern Trust
& 2 more
-
Employee Count
8300
as on Dec 31, 2024
-
Investments & Acquisitions
AvKARE
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Amneal
Amneal is a publicly listed company on the NASDAQ with ticker symbol AMRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Amneal
Amneal offers a comprehensive portfolio of products and services, including Generic Products, Specialty Products, and Biosciences Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Essential generic medicines for treating various common health conditions
Innovative drugs for specific diseases like Parkinson's and oncology
Advanced biosimilars for institutional and patient use worldwide
Unlock access to complete
Unlock access to complete
Human Resources and Administration
35 people
Leadership Team
24 people
Finance and Accounting
24 people
Software Development Team
21 people
Legal and Compliance
9 people
Product Management Team
3 people
Senior Team
3 people
Sr. Team
3 people
Unlock access to complete
Funding Insights of Amneal
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $19.2M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Post-IPO - Amneal | Valuation |
investors |
|
| Feb, 2015 | Amount | Debt – Conventional - Amneal | Valuation |
investors |
|
| Jun, 2005 | Amount | Series A - Amneal | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amneal
Amneal has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Northern Trust, GE Capital and Tarsadia. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private equity are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Financial and wealth management services are provided worldwide.
|
Founded Year | Domain | Location | |
|
Commercial aircraft and equipment leasing and lending services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amneal
Amneal has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutic solutions for rare diseases are developed.
|
2020 | ||||
|
Therapeutic products are developed and manufactured by Puniska.
|
2017 | ||||
|
Science-based nutrition products are developed for infants, children, and adults.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Amneal
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amneal Comparisons
Competitors of Amneal
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amneal
Frequently Asked Questions about Amneal
When was Amneal founded?
Amneal was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Where is Amneal located?
Amneal is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
How many employees does Amneal have?
As of Dec 31, 2024, the latest employee count at Amneal is 8,300.
What is the annual revenue of Amneal?
Annual revenue of Amneal is $2.79B as on Dec 31, 2024.
What does Amneal do?
Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.
What products or services does Amneal offer?
Amneal offers Generic Products, Specialty Products, and Biosciences Products.
Is Amneal publicly traded?
Yes, Amneal is publicly traded on NASDAQ under the ticker symbol AMRX.
How many acquisitions has Amneal made?
Amneal has made 6 acquisitions, including AvKARE, Epsilon Pharmaceuticals, and Gemini Laboratories.
Who are Amneal's investors?
Amneal has 3 investors. Key investors include Northern Trust, GE Capital, and Tarsadia.
What is Amneal's ticker symbol?
The ticker symbol of Amneal is AMRX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.